Trial Profile
A study to evaluate the assessment of morphological response in patients undergoing Chemotherapy for unresectable colorectal liver metastasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 27 Dec 2015 New trial record